Symposium Article
Multiple Chemical Sensitivities: A Symposium on the State of the Science Arlington, Virginia, November 19-20, 1992

https://doi.org/10.1006/rtph.1993.1045Get rights and content

Abstract

Multiple chemical sensitivities (MCS) defies diagnostic categorization because of its pansystemic manifestations, its lack of consistent symptomatology, and its absence of specific, measurable endpoints, either physical stigmata or laboratory findings. Controlled studies have been few and difficult to perform. Moreover, the phenomenon resists systematic investigation for two reasons. First, it has coalesced into a movement championed by zealous proponents and organized adherents. Second, it has gained support in the courts, the legislatures, and the regulatory agencies which have provided special protection and monetary rewards to this phenomenon before science and medicine have defined it as a medical disorder. One hotly contested issue in the MCS debate is the relative role of organic versus psychological contributions to the symptoms of MCS patients. This is a critical issue most importantly because it determines approaches to treatment, secondarily because it affects regulatory action, disability determination, and compensatability. The interest of the ISRTP in this phenomenon derives from the significant regulatory impact of this diagnosis on OSHA standards, EPA regulations, and FDA standards. The symposium was convened to explore the quality of the science underlying MCS with respect to diagnosis, and, particularly, to cause. The general objective of the symposium was to discuss the state of the science regarding MCS and its implications in regulatory toxicology, immunology, occupational medicine, psychiatry, psychology, epidemiology, and public health. The symposium was attended by a diverse audience representing the medical, scientific, business, legal, and regulatory communities. The majority of speakers critically questioned the characterization of MCS as a clinical entity, in light of historical comparisons to earlier false diagnoses, toxicological implausibility, and clinical inconsistencies.

References (0)

Cited by (29)

  • Idiopathic Environmental Intolerances

    2014, Encyclopedia of Toxicology: Third Edition
  • Multiple chemical sensitivities

    2005, Encyclopedia of Toxicology
  • Revision of the nomenclature of allergy (complete version)

    2004, Revue Francaise d'Allergologie et d'Immunologie Clinique
  • Multiple chemical sensitivities syndrome: A review

    1996, American Journal of Contact Dermatitis
View all citing articles on Scopus
View full text